Our portfolio is deep and diverse, meeting critical medical needs and providing a platform for sustainable growth.

Spread across five therapeutic areas and diagnostic products and services, Genzyme's portfolio balances risk while helping patients with serious medical conditions.

GENETICS/DIAGNOSTICS

• Reproductive Medicine
• Oncology
• Infectious Diseases
• Cardiovascular Diseases

GENETIC DISEASES

• Cerezyme® imiglucerase for injection
• Myozyme® algucosidase alfa
• Fabrazyme® agalsidase beta
• Aldurazyme® laronidase

RENAL DISEASE

• Renagel® sevelamer hydrochloride
• Hectorol® doxercalciferol

ORTHOPAEDICS/BIOSURGICAL SPECIALTIES

• Synvisc® hylan G-F 20
• Carticel® autologous cultured chondrocytes
• MACI® Matrix-assisted Autologous Chondrocyte Implantation
• Seprafilm™ Adhesion Barrier
• Epicel® cultured epidermal autografts

ONCOLOGY/ENDOCRINOLOGY

• Campath®/MabCampath® alemtuzumab
• Clolar® clofarabine
• Thyrogen® thyrotropin alfa for injection

TRANSPLANT/IMMUNE DISEASES

• Thymoglobulin® anti-thymocyte globulin rabbit
• Lymphoglobulin® anti-thymocyte globulin equine